Sasan Roayaie
Sasan Roayaie
White Plains Hospital - Montefiore health
Verified email at - Homepage
Cited by
Cited by
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
V Mazzaferro, JM Llovet, R Miceli, S Bhoori, M Schiavo, L Mariani, ...
The lancet oncology 10 (1), 35-43, 2009
The international position on laparoscopic liver surgery: The Louisville Statement, 2008
JF Buell, D Cherqui, DA Geller, N O’rourke, D Iannitti, I Dagher, AJ Koffron, ...
Annals of surgery 250 (5), 825-830, 2009
Gene expression in fixed tissues and outcome in hepatocellular carcinoma
Y Hoshida, A Villanueva, M Kobayashi, J Peix, DY Chiang, A Camargo, ...
New England Journal of Medicine 359 (19), 1995-2004, 2008
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
J Bruix, T Takayama, V Mazzaferro, GY Chau, J Yang, M Kudo, J Cai, ...
The lancet oncology 16 (13), 1344-1354, 2015
Pivotal role of mTOR signaling in hepatocellular carcinoma
A Villanueva, DY Chiang, P Newell, J Peix, S Thung, C Alsinet, V Tovar, ...
Gastroenterology 135 (6), 1972-1983. e11, 2008
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma
DY Chiang, A Villanueva, Y Hoshida, J Peix, P Newell, B Minguez, ...
Cancer research 68 (16), 6779-6788, 2008
Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis
P Tabrizian, G Jibara, B Shrager, M Schwartz, S Roayaie
Annals of surgery 261 (5), 947-955, 2015
Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma
E Wurmbach, Y Chen, G Khitrov, W Zhang, S Roayaie, M Schwartz, I Fiel, ...
Hepatology 45 (4), 938-947, 2007
A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma
S Roayaie, IN Blume, SN Thung, M Guido, MI Fiel, S Hiotis, DM Labow, ...
Gastroenterology 137 (3), 850-855, 2009
Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes
D Sia, Y Hoshida, A Villanueva, S Roayaie, J Ferrer, B Tabak, J Peix, ...
Gastroenterology 144 (4), 829-840, 2013
Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters
S Roayaie, JS Frischer, SH Emre, TM Fishbein, PA Sheiner, M Sung, ...
Annals of surgery 235 (4), 533-539, 2002
Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis
S Roayaie, JD Schwartz, MW Sung, SH Emre, CM Miller, GE Gondolesi, ...
Liver Transplantation 10 (4), 534-540, 2004
A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis
JM Llovet, Y Chen, E Wurmbach, S Roayaie, MI Fiel, M Schwartz, ...
Gastroenterology 131 (6), 1758-1767, 2006
Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma
A Villanueva, Y Hoshida, C Battiston, V Tovar, D Sia, C Alsinet, ...
Gastroenterology 140 (5), 1501-1512. e2, 2011
Resection of hepatocellular cancer≤ 2 cm: results from two Western centers
S Roayaie, K Obeidat, C Sposito, L Mariani, S Bhoori, A Pellegrinelli, ...
Hepatology 57 (4), 1426-1435, 2013
Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection
AWH Chan, J Zhong, S Berhane, H Toyoda, A Cucchetti, KQ Shi, T Tada, ...
Journal of hepatology 69 (6), 1284-1293, 2018
The role of hepatic resection in the treatment of hepatocellular cancer
S Roayaie, G Jibara, P Tabrizian, JW Park, J Yang, L Yan, M Schwartz, ...
Hepatology 62 (2), 440-451, 2015
Strategies for the management of hepatocellular carcinoma
M Schwartz, S Roayaie, M Konstadoulakis
Nature clinical practice Oncology 4 (7), 424-432, 2007
Massive parallel sequencing uncovers actionable FGFR2PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma
D Sia, B Losic, A Moeini, L Cabellos, K Hao, K Revill, D Bonal, ...
Nature communications 6 (1), 6087, 2015
Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo
P Newell, S Toffanin, A Villanueva, DY Chiang, B Minguez, L Cabellos, ...
Journal of hepatology 51 (4), 725-733, 2009
The system can't perform the operation now. Try again later.
Articles 1–20